High-dose vorinostat is effective in relapsed lymphomas
High doses of vorinostat (suberoylanilide hydroxamic acid) in combination with another round of commonly used second-line drugs produced a 70% response rate in patients with aggressive, relapsed lymphoma, including complete elimination of lymphoma cells in several patients.
